- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07679464
Aquatic Plyometrics for Adolescents With Patellofemoral Pain Syndrome
Hydro-Kinetic Plyometrics: A Randomized Clinical Assessment of Its Therapeutic Benefits for Adolescents With Patellofemoral Pain Syndrome
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Fifty-six adolescents diagnosed with PFPS were recruited from three major tertiary-care hospitals in Riyadh, Saudi Arabia. Inclusion criteria comprised individuals aged 10 to 18 years with a confirmed PFPS diagnosis (ICD-10 code: M22.2X9). Participants were required to present with chronic pain (>3 months in duration) scoring greater than 3 on a 0-to-10 numeric pain scale, which was exacerbated by physical activity and alleviated by rest. Exclusion criteria encompassed a history of knee surgery, acute knee trauma, patellar subluxation or dislocation, and the use of corticosteroids or anti-inflammatory medications within the preceding six months.
Outcome Measures
Pain Intensity: Assessed during both rest and physical movement using the 11-point Numerical Pain Rating Scale (NPRS), where 0 indicates "no pain" and 10 indicates "worst pain imaginable."
Muscle Strength: Measured as peak concentric torque (in Newton-meters [Nm]) of the quadriceps and hamstring muscle groups using an isokinetic dynamometer at an angular velocity of 120°/sec and 180°/sec.
Functional Disability: Evaluated using the Patellofemoral Disability Index (PDI), a self-reported questionnaire that measures the degree of functional limitation and difficulty an adolescent experiences when performing daily activities due to knee pain.
Quality of Life (QoL): Assessed using the Arabic version of the MOS 36-Item Short Form Health Survey (SF-36), a standardized patient-reported survey that evaluates physical and mental health components across eight health domains.
Interventions
The HK-Polyo group underwent a structured HK-Plyo program conducted in a water medium (pool). The intervention consisted of 24 total sessions, delivered twice a week for 12 consecutive weeks. Each 45-minute session included a 10-minute aquatic warm-up, a 30-minute core plyometric phase, and a 5-minute cool-down. The core phase consisted of 10 unilateral and bilateral lower-limb plyometric exercises, including variations of hopping, bounding, and jumping. Exercise prescription, progression, and safety parameters strictly adhered to the National Strength and Conditioning Association (NSCA) guidelines and the American Academy of Pediatrics (AAP) safety standards.
The control group underwent a standard, land-based exercise program. The intervention consisted of 24 total sessions, delivered twice a week for 12 consecutive weeks, with each session lasting 45 minutes. The program was multimodal and consisted of lower-limb flexibility exercises, progressive lower-extremity strength training, weight-bearing exercises, proprioceptive training, and balance exercises.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Riyadh Region
-
Al Kharj, Riyadh Region, Arabia Saudita
- Ragab K. Elnaggar
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Age of 10-18 years
- Verified diagnosis of PFPS based on the ICD classification system (ICD-10 code for PFPS: M22.2X9)
- Pain more than 3 on (0-10 pain scale).
- Persistent pain more than 3 months
- Pain get worse with activities and get better with rest.
Exclusion Criteria:
- History of knee surgery
- Recent trauma
- Corticosteroids or anti-inflammatory medications in the past 6 months
- Patellar subluxation or dislocation
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Gruppo di controllo
I partecipanti a questo gruppo hanno ricevuto il programma di esercizi standard.
|
Participants underwent a standard, land-based exercise program.
The intervention consisted of 24 total sessions, delivered twice a week for 12 consecutive weeks, with each session lasting 45 minutes.
The program was multimodal and consisted of lower-limb flexibility exercises, progressive lower-extremity strength training, weight-bearing exercises, proprioceptive training, and balance exercises.
|
|
Sperimentale: HK-Plyo group
Participants in this group underwent a structured HK-Plyo program.
|
Participants underwent a structured HK-Plyo program conducted in a water medium (pool).
The intervention consisted of 24 total sessions, delivered twice a week for 12 consecutive weeks.
Each 45-minute session included a 10-minute aquatic warm-up, a 30-minute core plyometric phase, and a 5-minute cool-down.
The core phase consisted of 10 unilateral and bilateral lower-limb plyometric exercises, including variations of hopping, bounding, and jumping.
Exercise prescription, progression, and safety parameters strictly adhered to the National Strength and Conditioning Association (NSCA) guidelines and the American Academy of Pediatrics (AAP) safety standards.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Pain Intensity
Lasso di tempo: 1 month
|
Assessed during both rest and physical movement using the 11-point Numerical Pain Rating Scale (NPRS), where 0 indicates "no pain" and 10 indicates "worst pain imaginable".
|
1 month
|
|
Muscle Strength
Lasso di tempo: 1 month
|
Measured as peak concentric torque (in Newton-meters [Nm]) of the quadriceps and hamstring muscle groups using an isokinetic dynamometer at an angular velocity of 120°/sec and 180°/sec.
|
1 month
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Functional Disability
Lasso di tempo: 1 month
|
Functional disability was assessed using the Patellofemoral Disability Index (PDI), a 10-item, self-administered questionnaire designed to quantify the functional limitations adolescents experience during daily activities secondary to knee pain.
Responses to each item were recorded on a 6-point ordinal scale ranging from 0 to 5. A score of 0 indicated no functional deficit, while a score of 5 signified severe symptom exacerbation or bedbound status.
The intermediate anchors represented a graded spectrum of impairment: 1 (minimal), 2 (minimal-to-moderate), 3 (moderate), and 4 (severe).
Individual item scores were summated to generate a total index ranging from 0 to a maximum of 50 points, wherein higher scores denoted progressively greater levels of disability.
|
1 month
|
|
Quality of life (QoL)
Lasso di tempo: 1 Month
|
Assessed using the Arabic version of the MOS 36-Item Short Form Health Survey (SF-36), a patient-reported instrument consisting of 36 items that evaluate physical and mental health across eight distinct domains.
Item-level responses were captured using varying Likert scales, which were subsequently coded and mathematically transformed according to standard SF-36 scoring algorithms.
This transformation yielded a standardized score ranging from 0 to a maximum of 100 points for each domain.
In this scoring metric, higher scores denoted a more favorable quality of life, whereas lower scores indicated poorer health status.
|
1 Month
|
Collaboratori e investigatori
Sponsor
Collaboratori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- RHPT/0023/0019
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .